HTA - 14/49/154
The Metoclopramide and selective oral decontamination for Avoiding Pneumonia after Stroke (MAPS-2) Trial: a 2x2 double-blind, randomized controlled trial of metoclopramide and selective oral decontamination for the prevention of pneumonia in patients with dysphagia after an acute stroke
Project title: The Metoclopramide and selective oral decontamination for Avoiding Pneumonia after Stroke (MAPS-2) Trial: a 2x2 double-blind, randomized controlled trial of metoclopramide and selective oral decontamination for the prevention of pneumonia in patients with dysphagia after an acute stroke
Chief investigator: Professor Christine Roffe
Contractor: University Hospitals of North Midlands NHS Trust
Co-investigators: Dr Adam Jeans, Dr Anushka Warusevitane, Dr Benjamin Bray, Dr Pelham Barton, Dr Tracy Nevatte, Miss Holly Maguire, Mr Brinton Helliwell, Mr Michael Harrison, Professor Craig Smith, Professor Julius Sim, Professor Margot Gosney.
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.
Background & Research Questions
Why the research is being done and what is being asked
Methods
How the research is being done
Publications & Outputs
What the research produced
Outcomes & Impact
What happened as a result of the research